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Summary
Background Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence 
and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease 
and common measures of socioeconomic status—wealth and education—differ among high-income, middle-income, 
and low-income countries, and, if so, why these differences exist. We explored the association between education and 
household wealth and cardiovascular disease and mortality to assess which marker is the stronger predictor of 
outcomes, and examined whether any differences in cardiovascular disease by socioeconomic status parallel 
differences in risk factor levels or differences in management.
Methods In this large-scale prospective cohort study, we recruited adults aged between 35 years and 70 years from 
367 urban and 302 rural communities in 20 countries. We collected data on families and households in 
two questionnaires, and data on cardiovascular risk factors in a third questionnaire, which was supplemented with 
physical examination. We assessed socioeconomic status using education and a household wealth index. Education 
was categorised as no or primary school education only, secondary school education, or higher education, defined as 
completion of trade school, college, or university. Household wealth, calculated at the household level and with 
household data, was defined by an index on the basis of ownership of assets and housing characteristics. Primary 
outcomes were major cardiovascular disease (a composite of cardiovascular deaths, strokes, myocardial infarction, 
and heart failure), cardiovascular mortality, and all-cause mortality. Information on specific events was obtained from 
participants or their family.
Findings Recruitment to the study began on Jan 12, 2001, with most participants enrolled between Jan 6, 2005, and 
Dec 4, 2014. 160 299 (87·9%) of 182 375 participants with baseline data had available follow-up event data and were 
eligible for inclusion. After exclusion of 6130 (3·8%) participants without complete baseline or follow-up data, 
154 169 individuals remained for analysis, from five low-income, 11 middle-income, and four high-income 
countries. Participants were followed-up for a mean of 7·5 years. Major cardiovascular events were more common 
among those with low levels of education in all types of country studied, but much more so in low-income 
countries. After adjustment for wealth and other factors, the HR (low level of education vs high level of education) 
was 1·23 (95% CI 0·96–1·58) for high-income countries, 1·59 (1·42–1·78) in middle-income countries, and 2·23 
(1·79–2·77) in low-income countries (pinteraction<0·0001). We observed similar results for all-cause mortality, with 
HRs of 1·50 (1·14–1·98) for high-income countries, 1·80 (1·58–2·06) in middle-income countries, and 2·76 
(2·29–3·31) in low-income countries (pinteraction<0·0001). By contrast, we found no or weak associations between 
wealth and these two outcomes. Differences in outcomes between educational groups were not explained by 
differences in risk factors, which decreased as the level of education increased in high-income countries, but 
increased as the level of education increased in low-income countries (pinteraction<0·0001). Medical care (eg, 
management of hypertension, diabetes, and secondary prevention) seemed to play an important part in adverse 
cardiovascular disease outcomes because such care is likely to be poorer in people with the lowest levels of 
education compared to those with higher levels of education in low-income countries; however, we observed less 
marked differences in care based on level of education in middle-income countries and no or minor differences in 
high-income countries.
Interpretation Although people with a lower level of education in low-income and middle-income countries have 
higher incidence of and mortality from cardiovascular disease, they have better overall risk factor profiles. However, 
these individuals have markedly poorer health care. Policies to reduce health inequities globally must include 
strategies to overcome barriers to care, especially for those with lower levels of education.
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Introduction
In high-income countries, low socioeconomic status is 
associated with an increased risk of cardiovascular 
disease and mortality.1–3 Whether this association also 
applies to low-income and middle-income countries, 
which have the highest burden of cardiovascular 
disease,4,5 has been less well studied, and findings on the 
association between socioeconomic status and cardio-
vascular health have been inconsistent.6,7 Clarifying the 
nature of the association between socioeconomic status 
and cardiovascular disease in low-income and middle-
income countries, and understanding the under lying 
reasons or related factors, is necessary for the develop-
ment of contextually appropriate strategies to mitigate 
health disparities. However, socioeconomic status is a 
multidimensional construct8 related to both adequacy of 
financial resources and educational attain ment. 
Therefore, the meaning and effects of socio economic 
status on cardio vascular disease might vary according to 
context, indicating the need for research in different 
settings. Specifically, with rapid urbanisation and societal 
change in low-income and middle-income countries, as 
well as increasing rates of cardiovascular disease, there is 
a need for up-to-date studies that can capture the current 
situation. Although some data exist on socioeconomic 
gradients in cardiovascular disease in low-income and 
middle-income countries,9–14 to our knowledge no study 
has used consistent methods to compare cardiovascular 
disease or death by socio economic status, nor has any 
study explored potential reasons for any observed 
differences. Furthermore, to our knowledge, existing 
studies have not used consistent methods or studied a 
large number of countries at different levels of economic 
development.
The Prospective Urban Rural Epidemiologic (PURE) 
study is a large-scale prospective cohort study that 
Research in context
Evidence before this study
We searched PubMed for articles published up to Feb 13, 2018, 
with the search terms (MESH and All Fields) “socioeconomic 
status”, “cardiovascular disease”, and “epidemiologic, 
comparison” and no language limits and identified 
266 abstracts; after addition of the term “management” another 
42 abstracts were returned. Furthermore, we used the 
Journal/Author Name Estimator search engine on the abstract of 
this manuscript to identify similar publications and found 
another 20 abstracts. Two authors (KBB, AR) searched all 
abstracts for cross-sectional and cohort studies that compared 
cardiovascular morbidity and mortality between countries of 
different socioeconomic levels (high-income, middle-income, 
and low-income countries) and between urban and rural 
communities. Altogether, we identified 49 relevant abstracts. 
We found several studies in high-income countries, but only 
altogether eight in other countries, that addressed disparities in 
socioeconomic position and cardiovascular complications and 
made comparisons between urban and rural areas. However, we 
found no studies that compared countries of high-income, 
low-income, and middle-income socioeconomic status in these 
respects. Therefore, although some data on socioeconomic 
gradients in cardiovascular disease in low-income and 
middle-income countries exist, we did not identify any that used 
consistent methods or compared findings across several 
countries at different levels of economic development.
Added value of this study
In high-income countries, low socioeconomic status is 
associated with an increased risk of cardiovascular disease. 
Whether this association also applies in low-income and 
middle-income countries, which have the largest burden of 
cardiovascular disease, has been less well studied and the 
results of existing studies are inconsistent. We found that low 
education was a stronger marker for cardiovascular disease 
and mortality than was wealth. This association was most 
marked in low-income countries (mainly India, Pakistan, and 
Bangladesh), less marked in middle-income countries, and 
least evident in high-income countries (mainly Canada and 
Sweden). Differences in risk factor proportions, which to a 
large extent were lower in individuals living in low-income 
countries, did not explain the different risks of cardiovascular 
disease in different educational groups. By contrast, less 
educated individuals in low-income countries received fewer 
medications for hypertension, diabetes, or secondary 
prevention and were less likely to quit smoking or have a 
healthy diet.
Implications of all the available evidence
Education, rather than wealth, was the factor most strongly 
associated with the study primary outcomes, with low 
education being associated with an increased risk of major 
cardiovascular disease and higher case fatality, despite lower 
proportions of cardiovascular risk factors in low-income 
countries than in high-income countries. Improved education 
and access to effective health care might mitigate some of the 
substantial excess burden of cardiovascular disease and 
mortality in low-income countries and narrow global health 
inequalities.
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Total patients Education
None or primary only Secondary Trade school, college, or 
university
High-income countries
Total number of people 17 241 (100·0%) 2137 (12·4%) 4995 (29·0%) 10 109 (58·6%)
Age (years) 52·2 (9·4) 55·1 (9·7) 52·4 (9·3) 51·5 (9·3)
Sex
Women 9241 (53·6%) 1289 (60·3%) 2739 (54·8%) 5213 (51·6%)
Men 8000 (46·4%) 848 (39·7%) 2256 (45·2%) 4896 (48·4%)
Urban 13 320 (77·3%) 1351 (63·2%) 3584 (71·8%) 8385 (82·9%)
Current use of at least one tobacco product per day 2307 (13·4%) 321 (15·0%) 896 (17·9%) 1090 (10·8%)
INTERHEART risk score 13·08 (6·1) 13·95 (6·2) 13·79 (6·3) 12·54 (5·9)
INTERHEART risk score without smoking 11·41 (5·4) 12·28 (5·6) 11·68 (5·5) 11·09 (5·3)
Hypertension* 6594/16 647 (39·6%) 1101/1915 (57·5%) 2051/4836 (42·4%) 3442/9896 (34·8%)
Diabetes, self-reported or on glucose-lowering agent 
(known diabetes)†
1609 (9·3%) 484 (22·6%) 458 (9·2%) 667 (6·6%)
Diabetes, self-reported or fasting glycaemia 
≥7 mmol/L or no-fasting glucose >7·7 mmol/L
1867 (10·8%) 536 (25·1%) 544 (10·9%) 787 (7·8%)
Cardiovascular disease‡ 1345 (7·8%) 246 (11·5%) 399 (8·0%) 700 (6·9%)
Middle-income countries
Total number of people 102 843 (100·0%) 45 820 (44·6%) 41 862 (40·7%) 15 161 (14·7%)
Age (years) 51·0 (9·6) 53·4 (9·6) 48·7 (8·9) 49·9 (9·8)
Sex
Women 60 397 (58·7%) 29 152 (63·6%) 23 564 (56·3%) 7681 (50·7%)
Men 42 446 (41·3%) 16 668 (36·4%) 18 298 (43·7%) 7480 (49·3%)
Urban 53 206 (51·7%) 15 920 (34·7%) 24 030 (57·4%) 13 256 (87·4%)
Current use of at least one tobacco product per day 21 610 (21·0%) 8955 (19·5%) 9816 (23·4%) 2839 (18·7%)
INTERHEART risk score 10·52 (5·8) 10·99 (5·8) 9·88 (5·6) 10·91 (5·9)
INTERHEART risk score without smoking 8·62 (5·1) 9·21 (5·2) 7·81 (4·9) 9·05 (5·2)
Hypertension* 41 932/96 628 (43·4%) 21 019/43 350 (48·5%) 15 234/38 701 (39·4%) 5679/14 577 (39·0%)
Diabetes, self-reported or on glucose-lowering agent 
(known diabetes)†
8229 (8·0%) 4234 (9·2%) 2721 (6·5%) 1274 (8·4%)
Diabetes, self-reported or fasting glycaemia 
≥7 mmol/L or no-fasting glucose >7·7 mmol/L
10 709 (10·4%) 5354 (11·7%) 3753 (9·0%) 1602 (10·6%)
Cardiovascular disease‡ 8950 (8·7%) 4488 (9·8%) 2922 (7·0%) 1540 (10·2%)
Low-income countries
Total number of people 34 085 (100·0%) 18 095 (53·1%) 11 653 (34·2%) 4337 (12·7%)
Age (years) 48·6 (10·3) 49·3 (10·7) 47·8 (9·8) 47·9 (9·9)
Sex
Women 19 446 (57·1%) 11 925 (65·9%) 5856 (50·3%) 1665 (38·4%)
Men 14 639 (42·9%) 6170 (34·1%) 5797 (49·7%) 2672 (61·6%)
Urban 15 514 (45·5%) 5096 (28·2%) 6680 (57·3%) 3738 (86·2%)
Current use of at least one tobacco product per day 7755 (22·8%) 5027 (27·8%) 2237 (19·2%) 491 (11·3%)
INTERHEART risk score 7·86 (5·0) 6·98 (4·6) 8·77 (5·3) 9·12 (5·4)
INTERHEART risk score without smoking 6·95 (4·8) 6·00 (4·4) 7·83 (5·0) 8·52 (5·1)
Hypertension* 10 122/31 233 (32·4%) 4598/16 085 (28·6%) 3906/11 017 (35·5%) 1618/4131 (39·2%)
Diabetes, self-reported or on glucose-lowering agent 
(known diabetes)†
3195 (9·4%) 1007 (5·6%) 1536 (13·2%) 652 (15·0%)
Diabetes, self-reported or fasting glycaemia 
≥7 mmol/L or no-fasting glucose >7·7 mmol/L
4343 (12·7%) 1474 (8·1%) 2040 (17·5%) 829 (19·1%)
Cardiovascular disease‡ 1530 (4·5%) 760 (4·2%) 583 (5·0%) 187 (4·3%)
Data are n (%), mean (SD), or n/N (%). *Self-reported or on medications, or blood pressure ≥140/≥90 mm Hg. †Plasma glucose concentrations were available in 122 711 participants. ‡Diagnosed with stroke, 
coronary heart disease, heart failure, or other heart disease before baseline visit.
Table 1: Participant characteristics stratified by education in high-income, middle-income, and low-income countries
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recruited individuals from high-income, low-income, 
and middle-income countries, providing an opportunity 
to explore associations between socioeconomic status 
and cardiovascular disease across settings at varying 
economic levels. In this Article, we describe the 
association between two markers of socioeconomic 
status (education and household wealth) and cardio-
vascular disease and mortality to assess which marker is 
the stronger predictor of outcomes. We also examined 
whether any differences in cardiovascular disease by 
socioeconomic status paralleled differences in risk factor 
levels or differences in management (using markers of 
health care such as hypertension control, diabetes care, 
and use of secondary prevention strategies).
Methods
Study design and participants
The design, methods (including sampling, information 
gathered, and follow-up strategy), and participant 
characteristics of the PURE study have been published 
previously.15 Briefly, adults aged between 35 years and 
70 years from 367 urban and 302 rural communities in 
20 countries (Tanzania, Zimbabwe, Bangladesh, Pakistan, 
India, occupied Palestinian territory, China, Colombia, 
Iran, South Africa, Malaysia, Argentina, Turkey, Brazil, 
Poland, Chile, Saudi Arabia, United Arab Emirates, 
Canada, and Sweden) were included. Details of sampling, 
information gathered, and follow-up strategy have been 
previously reported in several publications.15,16
For the present study, follow-up event data were 
available until Sept 20, 2017. The countries were grouped 
according to the 2006 World Bank income classifications17 
based on gross national product per capita at the time 
when data collection began (appendix). Men and women 
aged between 35 years and 70 years, who were expected to 
remain in their community for at least 4 years, were 
eligible for inclusion. The response rate was 72%. 
Although modest differences exist between the PURE 
household population and national data, these differences 
are unlikely to have much of an effect on the exposure–
disease associations derived in PURE, and demographics 
and mortality were generally similar to national statistics.18
Ethics committees at each centre approved the protocol 
and all participants provided written informed consent.
Procedures
We collected data on families and households in two 
questionnaires, the first recording sociodemographic 
information on all inhabitants of the household and the 
second recording information on house structure and 
amenities. Data on cardiovascular risk factors (tobacco 
use, history of hypertension, diabetes, psychosocial fac-
tors, diet, physical activity, and physical measures) were 
recorded using standardised questions and methods in a 
third questionnaire, which was sup plemented by physical 
examination, including blood pressure, anthropometric 
measures, spirometry, and an electrocardiogram. Further 
questionnaires assessed diet (food frequency) and 
physical activity by use of standardised instruments. 
Consenting participants also provided a fasting blood 
sample (appendix). The non-cholesterol INTERHEART 
risk score,19 which integrates information on age, sex, 
smoking, diabetes (self-report or fasting glucose 
>7·0 mmol/L), high blood pressure (blood pressure 
>140/>90 mm Hg or self-report), family history of heart 
disease, waist to hip ratio, psychosocial factors, diet 
(healthy eating score), and physical activity, was used to 
describe overall risk factor levels (appendix).15,16 The 
quality of data collection was maintained by the use of 
standardised protocols, centralised training, and stringent 
quality control at the project office.
We assessed socioeconomic status using education and 
a household wealth index. Education was categorised as 
no or primary school education only (lowest), secondary 
school education (intermediate), or higher education, 
defined as completion of trade school, college, or 
university (highest). Household wealth, calculated at the 
household level and with household data, was defined by 
an index on the basis of ownership of assets and housing 
characteristics,20 validated in several countries, and 
documented to be a robust measure of wealth, consistent 
with measures of income and expenditure.
Outcomes
Primary outcomes were major cardiovascular disease (a 
composite of cardiovascular deaths, strokes, myocardial 
infarction, and heart failure; appendix), cardiovascular 
mortality, and all-cause mortality.
Information on specific events was obtained from 
participants or their family, who were contacted at regular 
intervals after the questionnaires were delivered. Follow-
up of participants was done at 3-year intervals and 
information on clinical events was obtained from 
participants or family members for deceased participants. 
Figure 1: Age-standardised and sex-standardised proportion of participants 
with INTERHEART risk score >10 in high-income, middle-income, and 
low-income countries by education
Data are adjusted for age and gender. *Testing the interaction between country 
income and education.
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All follow-up visits were done either by visiting 
households or by telephone calls from participants, or, in 
countries such as Canada, the participants were invited 
to the central office to complete the follow-up visit. Events 
were adjudicated centrally in each country by trained 
physicians by use of standardised definitions, verbal 
autopsies, and review of documents.16 
Statistical analysis
We used direct standardisation to calculate the age-
standardised and sex-standardised incidence rates 
(per 1000 person-years) for cardiovascular events and 
deaths. We used multi-level Cox proportional hazard 
models to obtain the hazard ratios (HRs) for all-cause 
mortality, fatal cardiovascular disease, and major 
cardiovascular disease. In the multi-level structure 
models, we considered individual participants nested in 
centres and considered centres as a random intercept 
effect. We mutually adjusted HRs for education and 
wealth, in addition to age, sex, urban versus rural, 
baseline cardiovascular disease, and INTERHEART risk 
score. We included the interaction terms of region and 
education and region and wealth, where region denoted 
high-income, middle-income, or low-income countries. 
We tested the assumption of proportional hazard with 
log of the negative log of Kaplan-Meier estimates of the 
survival function versus the log time for evidence of non-
parallelism.
Defining countries according to country income might 
not adequately capture inequalities across the entire 
distribution of education or wealth. Consequently, we 
also used the Wagstaff index, which has been proposed 
as an alternative to the concentration index when the 
health variable is bounded (ie, has an upper and lower 
High-income countries Middle-income countries Low-income countries
Number of 
events
Age-standardised and 
sex-standardised 
event rate per 
1000 person-years 
(95% CI)
Number of 
events
Age-standardised and 
sex-standardised event 
rate per 
1000 person-years 
(95% CI)
Number of 
events
Age-standardised and 
sex-standardised 
event rate per 
1000 person-years 
(95% CI)
All-cause mortality 
By education
None or primary only 101 5·3 (4·2–6·4) 2683 8·1 (7·7–8·4) 2149 16·0 (15·0–17·0)
Secondary 116 2·9 (2·3–3·4) 1140 4·7 (4·4–5·0) 872 10·8 (10·0–12·0)
Trade school, college, or 
university
199 2·6 (2·2–3·0) 332 3·2 (2·9–3·6) 152 5·3 (4·2–6·5)
By wealth
Poorest third 168 3·8 (3·2–4·4) 1807 8·1 (7·7–8·5) 1471 16·4 (16·0–17·0)
Middle third 116 2·5 (2·0–3·0) 1327 5·6 (5·2–5·9) 974 13·7 (13·0–15·0)
Richest third 132 3·0 (2·4–3·6) 1021 4·6 (4·3–4·9) 728 8·7 (8·0–9·4)
Cardiovascular mortality
By education
None or primary only 25 1·3 (0·8–1·8) 841 2·4 (2·2–2·6) 627 4·6 (4·3–5·0)
Secondary 21 0·6 (0·3–0·8) 304 1·3 (1·1–1·5) 320 3·9 (3·4–4·4)
Trade school, college, or 
university
36 0·4 (0·3–0·6) 98 1·0 (0·8–1·2) 52 1·6 (1·1–2·2)
By wealth
Poorest third 41 1·0 (0·7–1·3) 566 2·5 (2·3–2·8) 366 4·1 (3·7–4·6)
Middle third 14 0·3 (0·1–0·4) 394 1·6 (1·4–1·7) 348 4·9 (4·4–5·5)
Richest third 27 0·6 (0·3–0·9) 283 1·3 (1·1–1·5) 285 3·3 (2·9–3·7)
Major cardiovascular disease
By education
None or primary only 127 7·3 (5·7–8·9) 2551 7·3 (6·9–7·6) 1038 7·5 (7·0–8·0)
Secondary 171 4·5 (3·8–5·3) 1493 5·8 (5·4–6·1) 645 7·7 (7·0–8·4)
Trade school, college, or 
university
293 3·7 (3·2–4·2) 506 4·9 (4·5–5·4) 112 3·5 (2·7–4·3)
By wealth
Poorest third 228 5·5 (4·7–6·3) 1748 7·4 (7·0–7·7) 587 6·3 (5·8–6·8)
Middle third 161 3·2 (2·6–3·7) 1506 6·1 (5·8–6·5) 614 8·5 (7·8–9·2)
Richest third 202 4·8 (4·0–5·5) 1296 5·6 (5·2–5·9) 594 6·9 (6·3–7·5)
For standardisation, the 2015 UN population data was used as the reference.
Table 2: Age-standardised and sex-standardised event rates per 1000 person-years by education and by country income
For UN population data see 
https://population.un.org/wpp/
DataQuery/
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limit).21,22 The Wagstaff index is the concentration index 
divided by 1 minus the mean of the health variable, 
producing a value between –1 and 1.
We calculated case fatality rates in the 28 days following 
myocardial infarction, stroke, and heart failure adjusted 
for age and sex. We calculated age-adjusted and sex-
adjusted case fatality rates by education or wealth and 
stratified by country income with the method of least 
squares to fit general linear models. Reported ptrend values 
on the figures are for case fatality rates within each 
country income grouping using the χ² test for trend. 
Given the multiple comparisons, p values should be 
interpreted with caution, unless very small (eg, p<0·0001). 
All analyses were done with SAS version 9.4 and all 
figures were drawn in R version 3.2.5.
Role of the funding source
The funders and sponsors of the study had no role in 
the study design and conduct, data collection, data 
analysis, data interpretation, writing of the report, or the 
decision to submit the manuscript for publication. The 
corresponding author had full access to all the data in 
the study and had final responsibility for the decision to 
submit for publication.
Results
Recruitment to the study began on Jan 12, 2001, with 
most participants enrolled between Jan 6, 2005, and 
Dec 4, 2014. 160 299 (87·9%) of 182 375 participants 
with baseline data had available follow-up event data, 
and were aged between 35 and 70 years and from 
20 countries (other countries and participants were 
enrolled too recently to have had a follow-up visit). 
After exclusion of 6130 (3·8%) partici pants without 
complete baseline or follow-up data, 154 169 remained 
for analysis (appendix). Populations had diverse sizes, 
with India contributing 81% of the low-income 
population, and China 45% of the middle-income 
Figure 2: HRs (95% CI) for all-cause mortality and major cardiovascular disease by country income and level of education
We included the interaction terms region and education, as well as region and wealth, where region denoted high-income, middle-income, or low-income countries. HR=hazard ratio. *Testing the 
interaction between country income and education or wealth.
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None or primary only
Secondary
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ptrend
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Secondary
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ptrend
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ptrend
Association of events by wealth
High-income countries
Poorest third
Middle third
Richest third
ptrend
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Middle third
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Poorest third
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ptrend
All-cause mortality
Events/total Adjusted HR (95% CI)
pinteraction value
101/2135
116/4985
199/10 065
2682/45 110
1134/41 135
331/14 967
2145/16 472
872/10 975
152/3974
168/4747
116/6213
132/6225
1805/33 071
1324/33 829
1018/34 312
1470/10 388
973/9945
726/11 088
1·50 (1·14–1·98)
0·99 (0·78–1·25)
1·00 (ref)
0·0149
1·80 (1·58–2·06)
1·37 (1·20–1·56)
1·00 (ref)
<0·0001
2·76 (2·29–3·31)
2·02 (1·69–2·42)
1·00 (ref)
<0·0001
1·15 (0·91–1·46)
0·84 (0·66–1·08)
1·00 (ref)
0·1279
1·27 (1·16–1·39)
1·06 (0·97–1·15)
1·00 (ref)
<0·0001
1·46 (1·29–1·65)
1·30 (1·17–1·45)
1·00 (ref)
<0·0001
0 0·5 1 1·5 2 2·5 3 3·5
<0·0001
0·0119
Major cardiovascular disease pinteraction value*
Events/total Adjusted HR (95% CI)
127/2135
171/4985
293/10 065
2549/45 110
1490/41 135
505/14 967
1034/16 472
645/10 975
112/3974
228/4747
161/6213
202/6225
1745/33 071
1505/33 829
1294/34 312
586/10 388
613/9945
592/11 088
0 0·5 1 1·5 2 2·5
<0·0001
0·0021
1·23 (0·96–1·58)
1·01 (0·83–1·22)
1·00 (ref)
0·1079
1·59 (1·42–1·78)
1·29 (1·16–1·43)
1·00 (ref)
2·23 (1·79–2·77)
2·01 (1·63–2·48)
1·00 (ref)
1·11 (0·91–1·35)
0·81 (0·66–1·00)
1·00 (ref)
0·4193
1·07 (0·98–1·17)
0·99 (0·92–1·07)
1·00 (ref)
0·0486
1·10 (0·95–1·28)
1·18 (1·04–1·33)
1·00 (ref)
0·3534
<0·0001
<0·0001
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population, whereas Canada contributed 60% of the 
high-income population.
4337 (12·7%) of 34 085 participants from low-income 
countries had a university, college, or trade school edu-
cation, compared with 15 161 (14·7%) of 102 843 par ticipants 
in middle-income countries and 10 109 (58·6%) of 
17 241 participants in high-income countries (table 1). 
Corresponding proportions for primary education or 
less were 18 095 (53·1%) for low-income countries, 
45 820 (44·6%) in middle-income countries, and 
2137 (12·4%) in high-income countries. Across all coun-
tries, participants with a high level of education were 
younger, and less likely to be women. In high-income 
countries, individuals with a low level of education had 
higher INTERHEART risk scores than did those with 
higher levels of education, and more frequently had 
hypertension, diabetes, and previous cardiovascular 
disease, whereas the opposite was true for low-income 
countries, with the exception of previous cardiovascular 
disease, which was similar across all education categories 
(table 1). We recorded the proportion of participants with 
INTERHEART risk scores score greater than 10 (figure 1). 
With respect to the findings for individual countries, 
India and Bangladesh, which constituted 88% of the low-
income population, both had higher INTERHEART risk 
scores among people with higher levels of education, 
although findings for the smaller samples in the other 
three low-income countries were heterogeneous (data not 
shown). Characteristics by wealth categories and 
individual components of the INTERHEART risk score 
by education are shown in the appendix.
Over a mean follow-up duration of 7·5 years until 
Sept 20, 2017, we recorded 7744 deaths and 6936 cases of 
major cardiovascular disease. Mortality varied sub-
stantially by education and country income (table 2), with 
the highest mortality in low-income countries and in 
those with the lowest levels of education across country 
income categories. The group with the lowest level 
of education in low-income countries had an age-
standardised and sex-standardised mortality rate of 16·0 
(95% CI 15·0–17·0) per 1000 person years—more than 
five times that of people with the highest level of education 
in high-income countries (2·6 per 1000 person-years, 
95% CI 2·2–3·0). Similar results were also seen for 
cardiovascular mortality (table 2). When stratified by 
household wealth, total and cardiovascular mortality rates 
varied from 16·4 (95% CI 16·0–17·0) and 4·1 (3·7–4·6) 
per 1000 person-years, respectively, among the poorest 
third of participants in low-income countries to 3·0 
(2·4–3·6) and 0·6 (0·3–0·9) per 1000 person-years, 
respectively, among the richest third of participants in 
high-income countries. Incidence of major cardiovascular 
disease was similar for people with the lowest levels of 
education across low-income, middle-income, and high-
income countries (7·5 per 1000 person-years, 95% CI 
7·0–8·0, in low-income countries, 7·3 per 1000 person-
years, 6·9–7·6, in middle-income countries, and 7·3 per 
Figure 3: Age-standardised and sex-standardised mortality (A) and cardiovascular disease incidence (B) per 
1000 person-years by level of education
Data are stratified by country and arranged by increasing GDP (data for categories with fewer than eight events 
not shown). GDP=gross domestic product.
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1000 person-years, 5·7–8·9, in high-income countries). 
The incidence rates for those with the highest level of 
education were 3·5 per 1000 person-years (95% CI 
2·7–4·3) in low-income countries, 4·9 per 1000 person-
years (4·5–5·4) in middle income countries, and 
3·7 per 1000 person-years (3·2–4·2) in high-income 
countries. The association between wealth and outcomes 
was weaker than the same comparisons between 
education and outcomes, and this was consistently 
observed among men and women (data not shown).
In multivariable models that simultaneously adjusted 
for education and wealth, in addition to age, sex, urban 
versus rural setting, baseline cardiovascular disease, 
and INTERHEART risk score, education was a strong 
independent predictor for total mortality (HR 2·76, 
95% CI 2·29–3·31, in low-income countries, 
1·80, 1·58–2·06, in middle-income countries, and 1·50, 
1·14–1·98, in high-income countries) when comparing 
the lowest level of education with the highest level of 
education (pinteraction<0·0001; figure 2). We observed 
similar results for major cardiovascular disease (2·23, 
1·79–2·77, for low-income countries, 1·59, 1·42–1·78, 
for middle-income countries, and 1·23, 0·96 to 1·58, 
for high-income countries; pinteraction<0·0001). Level of 
education was a far stronger predictor for major 
cardiovascular disease and all-cause mortality than was 
wealth. We also calculated mutually adjusted HRs by 
education and wealth, stratified by countries grouped 
by income, but adjusted for separate risk factors rather 
than the composite INTERHEART risk score 
(appendix). Sensitivity analyses from which subjects 
with previous cardiovascular disease were excluded 
provided similar results (appendix).
Cardiovascular event rates and death rates by individual 
country ranked by their gross domestic product (GDP) 
are shown in figure 3. The only low-income country with 
a sufficient number of events for analysis in people with a 
high level of education was India, but we observed similar 
patterns in the other low-income countries, for which we 
were able to compare middle and low levels of education.
The Wagstaff index results reaffirmed our conclusions, 
specifically that although the patterns of inequality were 
broadly similar for education and the wealth index, the 
strength of the association between education and out-
comes was stronger than the corresponding association 
between the wealth index and outcomes, as indicated by 
the relatively lower index estimates for wealth (appendix). 
Importantly, the index estimates were consistent with 
our conclusions from figure 2 and table 2.
5509 (79·4%) of 6936 major cardiovascular disease 
events recorded occurred in participants with no previous 
cardiovascular disease at baseline, of whom 1407 (25·5%) 
died within 28 days. We observed substantial differences 
between countries at different income levels with respect 
to absolute case fatality rates (CFRs), and in the 
association between level of education and CFR 
(pinteraction<0·0001 for country income and education; 
figure 4). The gradients in CFRs between the highest and 
the lowest levels of education were steepest in low-
income and middle-income countries, and we observed 
no gradient in high-income countries, where there were 
fewer overall fatalities. Corresponding data for wealth are 
shown in the appendix.
Hypertension and diabetes are among the most 
important risk factors for cardiovascular disease and 
related mortality and treating them is proven to reduce 
complications, as does secondary prevention in people 
with known cardiovascular disease. Therefore, we exam-
ined variations in the medical treatment of hypertension 
and diabetes, and in secondary prevention, by education 
and country income as a marker of management of these 
conditions (table 3). 27 327 (46·6%) of 58 642 participants 
with hypertension were aware of their condition. In the 
high-income countries included in our study, medical 
treatment did not vary by education, whereas we found a 
consistent and significant inverse association between 
level of education and treatment in low-income and 
middle-income countries (pinteraction<0·0001).
13 207 (8·6%) of 153 934 participants had known 
diabetes—1609 (9·3%) in high-income countries, 
8224 (8·0%) in middle-income countries, and 3194 (9·4%) 
in low-income countries (table 3). 1198 (74·5%) of 
1609 people with known diabetes in high-income 
countries used hypoglycaemic drugs, with no differences 
by education, and 4349 (52·9%) of 8224 people with 
known diabetes in middle-income countries used 
hypoglycaemic drugs, with slightly lower use with lower 
levels of education. Among those with the highest level 
of education in low-income countries, 248 (38·0%) of 
652 participants were on medication for their diabetes, 
but only 232 (23·1%) of 1006 participants with low levels 
of education also took such medication (odds ratio 
[OR] 0·43, 95% CI 0·34–0·54; pinteraction<0·0001; table 3).
We also examined differences in use of secondary 
prevention medications as a potential explanation of the 
Figure 4: 28-day CFR after a first cardiovascular event and OR by country income and level of education 
among participants without previous cardiovascular disease
pinteraction<0·0001 for country income and education. We adjusted ORs for age and sex. CFR=case fatality rate. 
OR=odds ratio.
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high mortality among people with low levels of edu-
cation in low-income and middle-income countries. 
11 825 (7·7%) of 153 934 study participants had a previous 
cardiovascular disease event at baseline (table 3). Use of 
at least one medication was reported by 1040 (77·3%) of 
1345 participants in high-income countries, 3617 (40·4%) 
of 8950 participants in middle-income countries, and 
240 (15·7%) of 1530 participants in low-income countries. 
In high-income countries, people with low education had 
higher use of any secondary prevention medication 
(OR 1·82, 95% CI 1·14–2·89), whereas there was no 
systematic variation in middle-income countries (OR for 
lowest level vs highest level of education 1·10, 95% CI 
0·95–1·28). In low-income countries, 60 (32·1%) of 
187 participants with the highest level of education and 
67 (8·8%) of 760 participants with no or primary 
education only used any secondary preventive drug 
(OR 0·26, 95% CI 0·17–0·42; pinteraction<0·0001).
Overall, quitting smoking was more common in those 
with higher education in all types of country—295 (77·4%) 
of 381 participants in high-income countries, 316 (53·6%) 
of 590 participants in middle-income countries, and 
21 (46·7%) of 45 participants in low-income countries 
with trade school, college, or university level education, 
compared with 82 (65·6%) of 125 participants in high-
income countries, 676 (48·0%) of 1408 participants in 
middle-income countries, and 57 (22·6%) of 
252 participants in low-income countries with no or 
primary only education (pinteraction 0·0387; table 3). A higher 
healthy diet score (alternative healthy eating index; 
appendix) was less common with lower levels of 
education across high-income, middle-income, and low-
income countries (table 3). High levels of physical activity 
were more common among those with low education in 
low-income countries, but we found no significant 
interaction between country income and education 
(p=0·2941; table 3).
Discussion
We found that socioeconomic gradients with respect to 
cardiovascular disease and mortality varied between 
high-income, middle-income, and low-income countries, 
with inverse gradients that were steepest in poorer 
countries. Variations in traditional risk factors, as 
captured by the INTERHEART risk score, did not explain 
the differences in outcomes by socioeconomic status, 
because risk factors were generally lower in those with 
lower levels of education in low-income countries. 
Education, rather than wealth, was the socioeconomic 
indicator most consistently associated with outcomes, 
and people with low levels of education in low-income 
and middle-income countries had a markedly higher risk 
of major cardio vascular events compared with those with 
higher levels of education. Socioeconomic differences in 
primary and secondary prevention were also pronounced, 
with the least advantaged people (ie, those with low levels 
of education in low-income countries) receiving very 
poor secondary prevention, and markedly poorer diabetes 
and hypertension treatment compared with all other 
groups. We also observed large differences in CFRs after 
an acute cardiovascular event across both income level of 
countries and education level, as well as the household 
wealth of people within each country; however, details of 
care during or immediately after an acute event were not 
available.
The inverse gradient between low socioeconomic 
status and cardiovascular disease in high-income 
countries has been well documented.1–3,23,24 However, 
although cardiovascular disease mortality has decreased 
rapidly in high-income countries, low-income and 
middle-income countries now face the greatest burden of 
cardiovascular disease.25 Discussion of the changing 
patterns in cardiovascular disease has been informed by 
the concept of the epidemiological transition—the shift 
from malnutrition and infectious diseases to degenerative 
or non-communicable diseases, such as cardiovascular 
disease, as major causes of death and disability, resulting 
in an increasing average life expectancy and brought 
about by industrialisation and urbanisation26,27—but what 
is currently happening is unclear.7 Although there are 
data on differences in risk factors by socioeconomic 
status in low-income and middle-income countries, there 
are sparse data on whether the incidence and mortality 
after a cardiovascular disease event vary by socioeconomic 
status in these countries.
In this study, education was the marker of socio-
economic status that we found to be most clearly linked 
with cardiovascular outcomes, consistent with our 
previous report from the INTERHEART study.28 Low 
education is a proxy for broader social disadvantage but 
might directly impair an individual’s ability to obtain 
effective care in several ways, including low awareness of 
the importance of seeking timely care or reduced access 
to information on how and where to obtain care and to 
overcome barriers that exist, both through formal 
channels and social networks. Lower education also 
reduces life opportunities more generally, meaning that 
individuals might not be able to afford necessary health 
care or might live in neighbourhoods with worse access 
to health-care facilities, especially in countries without 
universal health coverage.29–31 These factors act through-
out a person’s life. The effects of social and behavioural 
factors are important, particularly where health-care 
systems are unable to compensate for social and 
economic disadvantages among the poor and less 
educated. These factors are in line with our finding that, 
in low-income countries, individuals with lower levels of 
education with hypertension have a cumulative dis-
advantage from detection to treatment and control, as 
previously reported in Colombia.32 Consistent with this 
finding, we also showed that those with the lowest levels 
of education in low-income countries were disadvantaged 
in access to primary and secondary prevention, and, as 
previously noted, overall use of these medicines is also 
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alarmingly low in low-income and middle-income 
countries.33 Given these findings, it is unsurprising that 
we observed large differences by education in CFRs in 
low-income countries. This finding is also consistent 
with evidence from studies in India, where use of key 
treatments (thrombolytics, β blockers, lipid-lowering 
drugs, angiotensin-converting enzyme inhibitors or 
angiotensin II receptor blockers, percutaneous coronary 
intervention, and coronary artery bypass graft surgery) in 
patients with acute myocardial infarction differed 
substantially by socioeconomic status.34 Although the 
mechanisms that cause inequalities in access to health 
care might lead to differences in CFRs, the association 
with differences in incidence of cardiovascular disease 
might be less intuitive. However, we do know that most 
of a sizeable proportion of those enrolled in PURE who 
had either hypertension, diabetes, or cardiovascular 
disease were either suboptimally treated or not treated at 
all, particularly in low-income countries. Thus, there is 
potential for preventing many events by improving the 
use of simple proven treatments, especially in individuals 
with a lower level of education.
In addition to differences in medical management, 
other factors should be considered, because many people 
will be healthy before an event and not in need of 
medication. For example, differences in wealth might 
affect an individual’s ability to afford a healthier diet if 
certain components of a healthy diet, such as fruits and 
vegetables, are relatively more expensive and thus 
unaffordable to many, particularly in poorer countries.35 
People with low levels of education in low-income and 
middle-income countries had lower risk factor levels but a 
higher risk of cardiovascular disease compared to those 
with higher levels of education. This apparent paradox 
could be due to epigenetics,36 or weight gain during critical 
periods in childhood,37,38 adolescence, and adulthood,39 all 
areas for which systematic information, especially from 
middle-income and low-income countries, is lacking. 
Other unmeasured factors might include working 
conditions,40 other psychosocial stress factors,41 and 
poverty in early life.42
The main strengths of our study are the inclusion of 
many communities from several countries at different 
economic levels, a standardised and systematic approach 
to data collection, and use of both wealth and education 
as markers of socioeconomic status. Limitations of our 
study include grouping together of countries (within the 
broad categories of low-income or high-income) that are 
culturally and socially diverse, potentially also with 
respect to quality of education—the quality of education 
in low-income countries might be very different to that in 
high-income countries. However, PURE, like most other 
surveys on similar topics, did not collect data on the 
quality of education. Thus, although partici pants in 
PURE are broadly similar to the populations of the 
countries concerned,18 the effect of education and wealth 
on health might vary between different countries within 
the same region. This could reflect the mediating effect of 
welfare policies, or differences between ethnic groups, 
where belief systems or social networks might confer 
differing levels of resilience. For example, research in 
Europe shows that the adverse health effects of un-
employment differ among different models of the welfare 
state,43 and the association between wealth and self-rated 
health differs in ethnic groups in the USA.44 Furthermore, 
the magnitude of ethnic differences in mortality in some 
countries, including the USA, varies with independent 
measures of racism45 and with measures of political 
culture.46 However, disentangling these relationships is 
extremely complicated in a multi national study because 
of the very different national contexts.
Another limitation of this study is that the docu-
mentation of cardiovascular events, which to a large 
extent depended on admissions to hospital, might have 
been less complete for people with scarce financial 
resources. Therefore, event rates might have been even 
higher in those with the lowest levels of education or 
lowest wealth. However, it is possible that CFRs in low-
income and middle-income countries could have been 
inflated if non-fatal events were incompletely reported. 
Although we collected information from 20 countries, 
the results might not necessarily be applicable to other 
countries in the same income category that were not 
included. Our study is not intended to be globally 
representative, but instead the diversity of countries in 
the study reflects the patterns of different associations 
between socioeconomic status and risk factors, 
treatments, and events. To our knowledge, PURE is the 
largest prospective study to date with in-depth data on 
socioeconomic status, risk factors, treat ments, and fatal 
and non-fatal events. Nevertheless, our findings might 
not be applicable to some countries within a specific 
economic category—for example, the USA—where the 
social and health-care systems differ substantially from 
other high-income countries. Our findings should 
stimulate similar studies to PURE that involve additional 
countries. However, our data show considerable 
consistency in cardiovascular disease and mortality by 
education group within each of the 20 countries, which 
indicates our results are likely to be widely applicable.
In conclusion, cardiovascular disease in low-income 
countries is a problem predominantly among people 
with lower levels of education, whereas the situation in 
middle-income countries is more variable. Despite a 
lower risk factor burden among people with lower levels 
of education in low-income countries, we found higher 
rates of major cardiovascular disease. We observed 
marked differences between those with the highest levels 
of education and those with the lowest levels of education 
in the treatment of hyper tension and diabetes, secondary 
prevention, and CFRs, as markers of substandard 
management. Given the increasing prevalence of cardio-
vascular disease, diabetes, and hypertension in low-
income and middle-income countries, these findings are 
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important. The findings of this study emphasise the 
importance of better education, which in turn can lead to 
better care and more use of proven pharmacological 
therapies. Therefore, measures to address the reasons 
underlying why so many people struggle to obtain 
education, and to assist them to remedy this situation, 
are likely to mitigate some of the substantial excess 
burden of cardiovascular disease and mortality, especially 
among the least privileged in low-income countries.
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